The Wistar Institute
The Wistar Institute Names Gelvina Rodriguez Stevenson, Esq. as Vice President, General Counsel, Secretary and Government Relations
PHILADELPHIA — (July 13, 2022) — The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious diseases, is pleased to announce the appointment of Gelvina Rodriguez Stevenson, Esq., as vice president, gene…
Collaboration Advances DNA-delivered Antibodies to Prevent COVID-19
PHILADELPHIA — (July 7, 2022) — Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery…
Global Voices for HIV Advocacy and Cure Research Come Together at Wistar’s 26th Annual Jonathan Lax Lecture
This year, The Wistar Institute hosted the Annual Jonathan Lax Memorial Award Lecture virtually, bringing together HIV scientists and activists on a global stage. Celebrating 26 years of continuous HIV research collaboration, the event was streame…
Taking on Cancer
Philadelphia Business Journal senior health reporter John George hosted Taking on Cancer, a two-panel discussion that kicked off with perspectives from local research leaders at the helm of world-class research institutes and health care systems. …
Jonathan Lax Memorial Award Lecture Streams Globally
PHILADELPHIA—(June 23, 2022)—The Wistar Institute, a biomedical research leader in cancer, immunology, and infectious disease, announces that for the first time it will globally stream its 26th Annual Jonathan Lax Memorial Award Lecture, celebrati…
Wistar Scientists Identify Novel Therapeutic Approach to Re-activate Immune Response Against Tumors
PHILADELPHIA — (June 21, 2022) — Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates. Therefore, new therapeutic options such as targeted therapy that boosts anti-tu…
Wistar Institute Launches Bold Science // Global Impact Capital Campaign to Rechart the Future of Human Health
PHILADELPHIA — (June 16, 2022) —The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious disease, announces its Bold Science // Global Impact Capital Campaign to support a five-year plan that sets out …
Wistar’s Dr. Amelia Escolano Named 2022 Pew Scholar
PHILADELPHIA — (JUNE 14, 2022) — The National Advisory Committee of the Pew Scholars Program in the Biomedical Sciences, has chosen Amelia Escolano, Ph.D., Assistant Professor in The Wistar Institute’s Vaccine & Immunotherapy Center, to join t…
Pennsylvania Department of Labor and Industry and Legislator Tour Wistar
The Wistar Institute was awarded a PAsmart grant of $650,000 from the Pennsylvania Department of Labor & Industry to expand education and training programs further across the region and create additional opportunities for more students to prep…
Wistar Grows its Collaborative Network Offering Internships in Biotechnology and Life Sciences
Wistar’s Biomedical Technician Training (BTT) Program was developed with the commitment to provide its students hands-on training and industry experience not traditionally delivered in academic classrooms. The Wistar Institute’s training program h…